Announced, not yet open · HORIZON Research and Innovation Actions · HORIZON-HLTH-2027-01-DISEASE-05
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
Scope:
Infectious diseases remain a major threat to health and health security in the EU and globally. Viral disease emergence is already being accelerated by climate change, and thus a proactive approach to the development of antiviral prophylactics and therapeutics in preparedness for future infectious disease outbreaks is needed. The availability of antivirals targeting conserved viral or host mechanisms would provide a critical preparedness measure against future health threats caused by (re)emerging infectious disease epidemics or pandemics, due to infectious disease epidemics or pandemics.
This topic contributes to strengthening the Research and Innovation ecosystem within the EU and supports the implementation of the European Medical Countermeasures Strategy[1].
Antibodies and antibody derived proteins are excluded from the scope of this topic.
Trimmed here, the full scope, expected outcomes and award criteria are on the official topic page ↗.
| Item | Estimate | Note |
|---|---|---|
| Drafting effort | 6–8 weeks | single submission |
| Partner search | 4–8 weeks | runs in parallel, and it is the part that slips |
| Time to first payment | 6–9 months | cut-off → evaluation → grant agreement |
These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.
Two kinds of row. Most are the sentence we read the condition from, quoted out of the call itself. Some say plainly that they are not a quotation but the programme's own rule for this type of action, the EU portal publishes a table of contents where the conditions should be, so for a Research and Innovation Action the rate comes from the rulebook rather than from the fiche.
| Condition | Quoted from the call, or the rule behind it |
|---|---|
| Consortium size | Not quoted from this call — Research and Innovation Actions under the Horizon Europe rules are at least three independent legal entities from three different Member States or Associated Countries, at least one established in a Member State. |
| Funding rate | Not quoted from this call — Research and Innovation Actions under the Horizon Europe rules are funded at 100% of eligible costs for every participant. |
Eight questions, no account, nothing sent anywhere. You will know which of the 1526 open calls you can actually enter before you finish your coffee.
Check my fit
